CellaVision AB (publ) Interim report January - September 2011
(Thomson Reuters ONE) -
Substantially improved earnings and continued high growth
January 1 - September 30, 2011
* Net sales rose by 21 % to SEK 109.0 million (89.8)
* The operating result was SEK10.9 million (4.9)
* Profit before tax was SEK 11.2 million (1.2)
* Earnings per share were SEK 0.31 (0.05)
* Cash and cash equivalents at the end of the period were SEK 43.0 million
(30.8)
July 1 - September 30, 2011
* Net sales increased by 14 % to SEK 36.5 million (32.0)
* The operating result was SEK 3.7 million (2.2)
* Profit before tax was SEK 6.4 million (-2.1)
* Earnings per share were SEK 0.21 (-0.09)
* CellaVision receives an important order from a large Canadian laboratory
CellaVision in brief
(SEK million) Jul-Sep Jul-Sep Jan-Sep 2011 Jan-Sep Full year
2011 2010 2010 2010
Net sales 36.5 32.0 109.0 89.8 131.6
Gross profit 22.6 17.9 69.2 58.7 87.6
Operating result 3.7 2.2 10.9 4.9 13.9
Profit before tax 6.4 -2.1 11.2 1.2 10.7
Cash flow 0.4 5.7 7.2 8.8 13.8
CEO's comments: Milestone reached of 1000 analyzers sold and demand continues
strong for our products
"Sales and earnings for the third quarter have exceeded my expectations. The
reasons for the strong result are mainly increased sales in North America, a
good product mix and positive foreign exchange effects. Our contract
manufacturers carried out their planned move to a new production site without
major disruption and with retained capacity to meet our customers' requested
delivery times. Sales for the third quarter rose by 14 per cent and operating
profits improved to SEK 3.7 million.
During the quarter we proudly delivered our thousandth analyzer to Southampton
in southern England. The event is an important milestone in CellaVision's ten-
year history of sales and strengthens us for our continued efforts towards the
goal of being a global standard for digital microscopy in the field of
hematology. With customers soon in 50 countries, we are recognized by the market
as a supplier of products with a high level of customer benefit - and demand for
our digital solutions unquestionably exists even outside our main markets.
Our contract manufacturer's move, as I mentioned, has now been completed, giving
us the conditions we need to meet expected growth. There is still work to do to
secure supply of key components. This may still have a negative impact on the
supply situation, but I am confident in our ability to achieve a stable rate of
delivery adapted to even higher sales targets before the end of the year.
Nor do we see any dampening effect on sales from the uncertain economic
situation in the world. We are entering the last quarter of 2011 still as a
growing company, with a strong demand for our products, improved production and
supply potential, and a new product on its way."
Yvonne Mårtensson, CEO, CellaVision AB
CellaVision AB (publ) Interim report January 1 - September 30, 2011:
http://hugin.info/132164/R/1557597/480944.pdf
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: CellaVision AB via Thomson Reuters ONE
[HUG#1557597]
Unternehmensinformation / Kurzprofil:
Datum: 25.10.2011 - 15:00 Uhr
Sprache: Deutsch
News-ID 79968
Anzahl Zeichen: 4260
contact information:
Town:
Lund
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 189 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"CellaVision AB (publ) Interim report January - September 2011"
steht unter der journalistisch-redaktionellen Verantwortung von
CellaVision AB (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
